Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 11/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | KDM5A | P29375 | 1/20 | 0.36 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8090809 | 0.97 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL7033108 | 0.97 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4432484 | 0.97 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL1038060 | 0.97 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL8934997 | 0.97 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3095679 | 0.97 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL538822 | 0.97 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL18875934 | 0.97 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3791709 | 0.97 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3675109 | 0.97 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2098316-A2 | Metal nanoparticles stabilized with a bident amine | Xerox Corporation (US) | 2009-09-09 | — | — | EP | claimed |
| US-20090214764-A1 | METAL NANOPARTICLES STABILIZED WITH A BIDENT AMINE | XEROX CORPORATION (US) | 2009-08-27 | — | — | US | claimed |
| CN-119800065-A | Tungsten extractant, preparation method thereof and method for extracting and separating tungsten | 郑州大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-119800064-A | Extractant for extracting and separating tungsten and molybdenum and application thereof | 郑州大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-116607132-A | Plating bath composition for electroless gold plating and method of depositing gold layer | 埃托特克德国有限公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-109071580-B | Material for organic electroluminescent device | 默克专利有限公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-102405209-A | Diacylethylenediamine compound | ASTELLAS PHARMA INC | 2012-04-04 | — | — | CN | disclosed |
| EP-2423182-A1 | DIACYLETHYLENEDIAMINE COMPOUND | Astellas Pharma Inc. (JP) | 2012-02-29 | — | — | EP | disclosed |
| EP-2423182-A1 | DIACYLETHYLENEDIAMINE COMPOUND | Astellas Pharma Inc. (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120046292-A1 | DIACYLETHYLENEDIAMINE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2012-02-23 | — | — | US | disclosed |
| US-20120046292-A1 | DIACYLETHYLENEDIAMINE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2012-02-23 | — | — | US | disclosed |
| EP-2157215-B1 | POLYURETHANE ELASTIC FIBER | ASAHI KASEI FIBERS CORP (JP) | 2011-12-28 | — | — | EP | disclosed |
| WO-2010122968-A1 | DIACYLETHYLENEDIAMINE COMPOUND | アステラス製薬株式会社 (JP) | 2010-10-28 | — | — | WO | disclosed |
| US-20100184347-A1 | POLYURETHANE ELASTIC FIBERS | ASAHI KASEI FIBERS CORPORATION (JP) | 2010-07-22 | — | — | US | disclosed |
| EP-2157215-A1 | POLYURETHANE ELASTIC FIBER | Asahi Kasei Fibers Corporation (JP) | 2010-02-24 | — | — | EP | disclosed |
| EP-2098316-A2 | Metal nanoparticles stabilized with a bident amine | Xerox Corporation (US) | 2009-09-09 | — | — | EP | disclosed |
| US-20090214764-A1 | METAL NANOPARTICLES STABILIZED WITH A BIDENT AMINE | XEROX CORPORATION (US) | 2009-08-27 | — | — | US | disclosed |
| US-20090012288-A1 | Process for preparation of pentostatin (R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz[4,5-d][1,3] diazepin-8-ol | ZHANG HAI-REN | 2009-01-08 | — | — | US | disclosed |
| US-5360564-A | Hydrogenated star polymers | SHELL OIL COMPANY (US) | 1994-11-01 | — | — | US | disclosed |
| US-5073600-A | Aminated graft polymer oil additive | SHELL OIL COMPANY (US) | 1991-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046292-A1 | DIACYLETHYLENEDIAMINE COMPOUND | DGAT1, DGAT2, DIMT1 | DNM1 950/4885TSHR 4189/4885MEN1 2222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.